SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
方莉
Lv4
520 积分
2022-11-21 加入
最近求助
最近应助
互助留言
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
1个月前
已完结
First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer
1个月前
已完结
Emerging Treatment Paradigms for EGFR-Mutant Lung Cancers Progressing on Osimertinib: A Review
1个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
1个月前
已完结
Early clearance of plasma EGFR mutations as a predictor of response to osimertinib in the AURA3 trial
1个月前
已关闭
Complete clearance of plasma EGFR mutations as a predictor of outcome on osimertinib in the AURA trial
1个月前
已关闭
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results
1个月前
已完结
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
1个月前
已完结
Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations
1个月前
已完结
Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients
1个月前
已完结
没有进行任何应助
么么哒
9个月前
速度真快
9个月前
么么哒
9个月前
速度真快
9个月前
帮大忙了
9个月前
速度真快
9个月前
感谢
9个月前
速度真快
9个月前
点赞
11个月前
感谢
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论